Design Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DSGN and other ETFs, options, and stocks.

About DSGN

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. 

CEO
Joao Siffert
CEOJoao Siffert
Employees
38
Employees38
Headquarters
Carlsbad, California
HeadquartersCarlsbad, California
Founded
2017
Founded2017
Employees
38
Employees38

DSGN Key Statistics

Market cap
910.79M
Market cap910.79M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
634.57K
Average volume634.57K
High today
$17.05
High today$17.05
Low today
$16.13
Low today$16.13
Open price
$17.05
Open price$17.05
Volume
395.11K
Volume395.11K
52 Week high
$26.30
52 Week high$26.30
52 Week low
$9.61
52 Week low$9.61

DSGN Earnings

-$0.31
-$0.21
-$0.10
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.